J.‐C. Dubus - Concepedia

Author

J.‐C. Dubus

Also Known As

A Karaulov, David Drummond, Dubus, J. -C., Dubus, J.C., Dubus, Jean-Christophe, Guillaume Thouvenin, J C Dubus, J Dubus, J-C Dubus, J-C. Dubus

423

Publications

7.6K

Citations

H-Index

116

Concepts

All Affiliations

Hôpital de la Timone Inserm Centre National de la Recherche Scientifique Aix-Marseille Université Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes

About

J.‐C. Dubus is an author at Hôpital de la Timone specializing in medicine, pediatrics, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	41	2K
2	Public Health	10	10	295
3	Allergy	6	6	333
4	Health Sciences	3	3	90
5	Education	1	1	28

J.‐C. Dubus

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease Pierre‐Régis Burgel, I. Durieu, R. Chiron, American Journal of Respiratory and Critical Care Medicine	2021	227
Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients Fadi Bittar, Hervé Richet, J.‐C. Dubus, PLoS ONE	2008	220
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients Marie‐Louise Frémond, Alice Hadchouel, Laureline Berteloot, The Journal of Allergy and Clinical Immunology In Practice VasculitisPediatricsSting-associated VasculopathySclerodermaMedicine	2020	197
Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey A. Deschildre, Christophe Marguet, Julia Salleron, European Respiratory Journal	2013	189
Local side‐effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device J.‐C. Dubus, C. Marguet, A. Deschildre, Allergy	2001	168
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden Nikolaos G. Papadopoulos, Adnan Ćustović, A. Deschildre, The Journal of Allergy and Clinical Immunology In Practice AsthmaPractice AdjustmentsAllergyDisease BurdenPediatric Epidemiology	2020	164
Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage Jean‐Marc Rolain, Patrice François, David Hernández, Biology Direct	2009	143
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis Rebecca Cosgriff, Susannah Ahern, Scott C. Bell, Journal of Cystic Fibrosis Sars-cov-2 InfectionRespiratory DiseasesCovid-19 PandemicRespiratory InfectionInfectious Respiratory Disease	2020	136
Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation) Cécile Picard, Guillaume Thouvenin, Caroline Kannengiesser, CHEST Journal Tmem173 MutationFibrosisPulmonary PathologyInflammatory Lung DiseaseLung Inflammation	2016	133
Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Pierre‐Régis Burgel, À. Munck, I. Durieu, American Journal of Respiratory and Critical Care Medicine	2019	127

Page 1